Abstract
Background Low intensity transcranial electrical stimulation (tES), including alternating or direct current stimulation (tACS or tDCS), applies weak electrical stimulation to modulate the activity of brain circuits. Integration of tES with concurrent functional magnetic resonance imaging (fMRI) allows for the mapping of neural activity during neuromodulation, supporting causal studies of both brain function and tES effects. Methodological aspects of tES-fMRI studies underpin the results, and reporting them in appropriate detail is required for reproducibility and interpretability. Despite the growing number of published reports, there are no consensus-based checklists for disclosing methodological details of concurrent tES-fMRI studies.
Objective To develop a consensus-based checklist of reporting standards for concurrent tES-fMRI studies to support methodological rigor, transparency, and reproducibility (ContES Checklist).
Methods A two-phase Delphi consensus process was conducted by a steering committee (SC) of 13 members and 49 expert panelists (EP) through the International Network of the tES-fMRI (INTF) Consortium. The process began with a circulation of a preliminary checklist of essential items and additional recommendations, developed by the SC based on a systematic review of 57 concurrent tES-fMRI studies. Contributors were then invited to suggest revisions or additions to the initial checklist. After the revision phase, contributors rated the importance of the 17 essential items and 42 additional recommendations in the final checklist. The state of methodological transparency within the 57 reviewed concurrent tES-fMRI studies was then assessed using the checklist.
Results Experts refined the checklist through the revision and rating phases, leading to a checklist with three categories of essential items and additional recommendations: (1) technological factors, (2) safety and noise tests, and (3) methodological factors. The level of reporting of checklist items varied among the 57 concurrent tES-fMRI papers, ranging from 24% to 76%. On average, 53% of checklist items were reported in a given article.
Conclusions Use of the ContES checklist is expected to enhance the methodological reporting quality of future concurrent tES-fMRI studies, and increase methodological transparency and reproducibility.
Competing Interest Statement
The City University of New York holds patents on brain stimulation with Marom Bikson as inventor. Marom Bikson has equity in Soterix Medical Inc. Marom Bikson consults, received grants, assigned inventions, and/or serves on the SAB of Boston Scientific, GlaxoSmithKline, Mecta, Halo Neuroscience, X. Christoph S. Herrmann holds a patent for transcranial electric stimulation. Michael A. Nitsche is on the Scientific Advisory Boards of Neuroelectrics, and Neurodevice. Giulio Ruffini is a co-founder and works for Neuroelectrics, a company dedicated to providing non-invasive stimulation solutions for patients. Klaus Schellhorn is Managing Director of neuroConn GmbH and a shareholder in neurocare group AG. Hartwig R. Siebner has received honoraria as speaker from Sanofi Genzyme, Denmark and Novartis, Denmark, as consultant from Sanofi Genzyme, Denmark and Lundbeck AS, Denmark, and as editor-in-chief (Neuroimage Clinical) and senior editor (NeuroImage) from Elsevier Publishers, Amsterdam, The Netherlands. He has received royalties as book editor from Springer Publishers, Stuttgart, Germany and from Gyldendal Publishers, Copenhagen, Denmark.
Funding Statement
Rany Abend is partially supported by the National Institute of Mental Health Intramural Research Program. Jorge Almeida is supported by the European Research Council (ERC) under the European Union Horizon 2020 research and innovation programme (Grant agreement No. 802553 - ContentMAP) and by grant PTDC/PSI-GER/30745/2017 from Fundacao para a Ciencia e a Tecnologia Portugal, and Programa COMPETE. Andrea Antal is supported by the Ministry for Science and Culture of Lower Saxony Germany (76251-12-7/19 ZN 3456) and by the BMBF (STIMCODE 01GP2124B). Daria Antonenko is supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation (AN 1103/3-1). Chris Baeken is supported by the Research Foundation Flanders (FWO) and the Queen Elisabeth Medical Foundation for Neurosciences. Helen Barron is supported by the Medical Research Council (MRC) UK (MC_UU_00003/4 and MC_UU_12024/3). Til Ole Bergmann is supported by the Boehringer Ingelheim Foundation and the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation, Grant 362546008). Marom Bikson is supported by grants from Harold Shames and the National Institutes of Health: NIH-NIDA UG3DA048502, NIH-NIGMS T34GM137858, NIH-NINDS 1R01NS112996, NIH-NINDS 1R01NS101362, NIH-NIMH 1R01MH111896, and NIH-NINDS 1R01NS095123. Matthew H. Davis is supported by the UK Medical Research Council (SUAG044/G101400). Hamed Ekhtiari is supported by the Laureate Institute for Brain Research (LIBR), Warren K. Family Foundation, Oklahoma Center for Advancement of Science and Technologies (OCAST, #HR18-139) and Brain and Behavior Foundation (NARSAD Young Investigator Award #27305). Valentina Fiori is supported by the Italian Ministry of Health (grant GR-2018-12365991). Peyman Ghobadi-Azbari is supported by the Cognitive Science and Technologies Council (grand CSTC-7761). Iman Ghodratitoostani is supported (grant number: 2013/07375-0) by Innovation and Diffusion of Mathematical Sciences Center Applied to Industry (CEPID-CeMEAI) of Sao Paulo Research Foundation (FAPESP), the University of Sao Paulo. Gadi Gilam is supported by the Redlich Pain Research Endowment and the Feldman Family Foundation Pain Research Fund. Gesa Hartwigsen is supported by the Max Planck Society and by the German Research Foundation (HA 6314/3-1, HA 6314/4-1 and HA 6314/9-1). Tobias U. Hauser is supported by a Sir Henry Dale Fellowship (211155/Z/18/Z) from Wellcome & Royal Society, an ERC Starting Grant, a grant from the Jacobs Foundation (2017-1261-04), the Medical Research Foundation, and a 2018 NARSAD Young Investigator grant (27023) from the Brain & Behavior Research Foundation. Christoph S. Herrmann is supported by the German Federal Ministry of Education and Research (BMBF, grant nrs. 16SV7787 and 13GW0273D) as well as the German Research Foundation under Germany Excellence Strategy (DFG, grant nr. EXC 2177/1 Project ID 390895286). Chi-Hung Juan is supported by the Ministry of Science and Technology, Taiwan (grant no.108-2639-H-008-001-ASP; 108-2321-B-075 -004 -MY2) and sponsored by Taiwan Ministry of Education Academic Strategic Alliance: Taiwan and Oxford University project grant. Daniel Keeser is supported by the German Center for Brain Stimulation (GCBS) research consortium (Work Package 5, Grant no. 01EE1403E), funded by the German Federal Ministry of Education and Research (BMBF). Bart Krekelberg is supported by the National Institute of Neurological Disorders and Stroke and the National Institute of Mental Health under awards R01MH111766 and R21MH113917. Lucia M. Li is supported by an NIHR Clinical Lectureship, Academy of Medical Sciences Starter Grant and the NIHR Brain Injury MedTech Cooperative. Sook-Lei Liew is supported by the National Institutes of Health (K01 HD091283, R01 NS115845). Timothy J. Meeker is supported by a Postdoctoral Scholarship from the Neurosurgery Pain Research Institute at the Johns Hopkins Medical Institute and National Institutes of Health (R01 NS107602). Marcus Meinzer is supported by the German Research Foundation (DFG ME 3161/3-1). Michael A. Nitsche is supported by Deutsche Forschungsgemeinschaft (DFG) - Projektnummer 316803389 SFB 1280 "Funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) - Projektnummer 316803389 - SFB 1280, the German Federal Ministry of Education and Research (BMBF, GCBS grant 01EE1501), and the EU (NEUROTWIN, grant 101017716). Alexander Opitz is supported by RF1MH117428 and RF1MH124909. Christian Ruff is supported by an ERC Consolidator grant (BRAINCODES, Grant #725355) and by the Swiss National Science Foundation (Grant # 100019L_173248). Michaela Ruttorf was supported by Deutscher Akademischer Austauschdienst (DAAD - Project-ID 57212180). Gottfried Schlaug acknowledges support by U01NS102353 and R01MH111874. A. Duke Shereen is supported by National Institute of Neurological Disorders and Stroke under award R21NS115018. Hartwig R. Siebner holds a 5-year professorship in precision medicine at the Faculty of Health Sciences and Medicine, University of Copenhagen which is sponsored by the Lundbeck Foundation (Grant Nr. R186-2015-2138). Hartwig R. Siebner has received a Lundbeckfonden Collaborative Alliance grant (Grant Nr. R336-2020-1035). Hartwig R. Siebner and Axel Thielscher are supported by the Innovationfund Denmark - grant agreement number 9068-00025B. Charlotte Stagg holds a Sir Henry Dale Fellowship, funded by the Wellcome Trust and the Royal Society (102584/Z/13/Z). Benjamin Thompson is supported by CIHR grant 390283, CFI grant 34095 and NSERC grants RPIN-05394 and RGPAS-477166. Axel Thielscher was supported by the Lundbeck foundation (R244-2017-196 and R313-2019-622). Dagmar Timmann is supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) - Projektnummer 316803389 - SFB 1280. Ines Violante and Tibor Auer are supported by the BBSRC (BB/S008314/1). Benedikt Zoefel is supported by the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement number 743482. The views presented in this manuscript represent those of the authors and not necessarily those of the funding agencies.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No ethics board approval was required for this expert panel activity. This consensus-seeking activity neither involved novel experimental work nor novel analyses of existing experimental data, but relied entirely on mutual exchange of expertise and opinions within the panel taking into account all existing peer-reviewed scientific studies on concurrent tES-fMRI. Potential contributors were informed that by responding to the invitation letter, they were deemed to have consented to take part in the Delphi study and that their de-identified responses are included in all analyses. All named contributors also provided consent to be acknowledged in this paper.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The results of each phase were summarized and displayed on the OSF page: https://osf.io/f9j8z/
